JSPR•benzinga•
Jasper Therapeutics Announces Plans For Registrational Study Of JSP191 In Older Patients With Myelodysplastic Syndromes Or Acute Myeloid Leukemia Undergoing Hematopoietic Cell Transplantation After Type C FDA Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2022 by benzinga